| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 79.89 Billion | USD 137.29 Billion | 6.2% | 2024 |
FrequentlyAsked Questions
In vitro diagnostic refers to the medical devices that need the help of reagents and assays to diagnose a medical condition.
The global in vitro diagnostics (IVD) market is expected to grow due to increasing demand for early disease detection, rising prevalence of chronic diseases, advancements in diagnostic technologies, growing healthcare infrastructure, and the shift towards personalized medicine.
According to a study, the global in vitro diagnostics (IVD) market size was worth around USD 79.89 Billion in 2024 and is expected to reach USD 137.29 Billion by 2034.
The global in vitro diagnostics (IVD) market is expected to grow at a CAGR of 6.2% during the forecast period.
North America is expected to dominate the in vitro diagnostics (IVD) market over the forecast period.
Leading players in the global in vitro diagnostics (IVD) market include QIAGEN N.V., Ortho Clinical Diagnostics, DiaSorin, bioMérieux, Sysmex Corporation, Bio-Rad Laboratories, Becton, Dickinson and Company, Johnson & Johnson, Thermo Fisher Scientific, Danaher Corporation, Siemens Healthineers, and Roche Diagnostics, among others.
The report explores crucial aspects of the in vitro diagnostics (IVD) market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients